Tingling. Tingling sensation
Conditions
Interventions
Intervention 1: 75 miligrams of 5% lidocaine, made in Gostaresh Bazargani Daroopakhsh will be injected intrathecally. Intervention 2: 12 miligrams of 0.5% bupivacaine, made in Iran Esalat company wil
Prevention
75 miligrams of 5% lidocaine, made in Gostaresh Bazargani Daroopakhsh will be injected intrathecally.
12 miligrams of 0.5% bupivacaine, made in Iran Esalat company will be injected intrathecally.
Sponsors
Arak University of Medical Sciences, Vice Chancellor for Research
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1. Women between 20 to 45 years old 2. Term pregnancy 3. Elective cesarean 4. No history of back pain, weakness and numbness in the extremities Exclusion criteria: 1. Underlying diseases such as pre-eclampsia and eclampsia Hypertension 2. Adding epinephrine or opiate to drugs 3. Using a needle with a larger size
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tingling. Timepoint: Immediately, 6, 12, and 24 hours after cesarean. Method of measurement: based on a scale of four.;Pain. Timepoint: Immediately, 6, 12, and 24 hours after cesarean. Method of measurement: Visual Analog Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAfsaneh Norouzi
Arak University of Medical Sciences
Outcome results
None listed